Outpatient treatment of deep vein thrombosis: translating clinical trials into practice

This publication has 73 references indexed in Scilit:

• Are the pharmacokinetic parameters of low molecular weight heparins predictive of their clinical efficacy?
  Thrombosis Research, 1996
• Subcutaneous Low-Molecular-Weight Heparin Compared With Continuous IntravenoUnfractionated Unfractionated Heparin in the Treatment of Proximal Deep Vein Thrombosis
  Archives of internal medicine (1960), 1993
• Randomized trial of subcutaneous low-molecular-weight heparin CY 216 (Fraxiparine) compared with intravenous unfractionated heparin in the curative treatment of submassive pulmonary embolism. A dose-ranging study.
  Circulation, 1992
• Usefulness of Thrombelastography for Dosage Monitoring of Low Molecular Weight Heparin and Unfractionated Heparin During Hemodialysis
  Artificial Organs, 1990
• Unfractionated Heparin and CY 216: Pharmacokinetics and Bioavailabilities of the Antifactor Xa and IIa Effects after lntravenous and Subcutaneous Injection in the Rabbit
  Thrombosis and Haemostasis, 1989
• Comparison of the platelet pro‐aggregatory effect of conventional unfractionated heparins and a low molecular weight heparin fraction (CY 222)
  British Journal of Haematology, 1987
• A comparison of the anti thrombotic and haemorrhagic effects of low molecular weight heparin fractions: The influence of the method of preparation
  Thrombosis Research, 1984
• Anticoagulant activities and effects on platelets of a heparin fragment with high affinity for antithrombin
  Thrombosis Research, 1980
• Effect of Heparin and Heparin Fractions on Platelet Aggregation
  Journal of Clinical Investigation, 1980
• Heparin and dextran sulfate antagonize PGI2 inhibition of platelet aggregation
  Thrombosis Research, 1979